Buranrat et al. reported that the combination of DOX and SIM increased cytochrome c protein expression and caspase-3 activity compared to each drug alone, suggesting that SIM sensitizes MCF-7 breast tumor cells, potentiating the action of DOX [47]. The gene discussed is CASP3; the disease is breast neoplasm.